Iambic Therapeutics, Inc.
New Filing
CIK: 0001997038·Biotechnology·DELAWARE·Filed: Sep 9, 2026
Total Offering
$66,500,000
Amount Sold
$65,965,000
Investors
16
First Sale
Aug 14, 2026
Offering Details
- Type
- Debt
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Thomas Miller | |
| Fred Manby | |
| Neil Josephson | |
| Michael Secora | |
| Jishnu Bhattacharjee | |
| Evan Rachlin | |
| R. Jacob Vogelstein | |
| Mary Tagliaferri | |
| William Rastetter | |
| Kurt von Emster | |
| Shalini Sharp | |
| Pete Olson | |
| Samit Hirawat |
Company
SEC Filing
0001997038-26-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free